Human coagulation factor Ⅷ (Wuhan Zhong Yuan Rui De)

人凝血因子Ⅷ（武汉中原瑞德）

Report date: 2022/01/17 12:14:22

Base Information

Drug NameHuman coagulation factor Ⅷ (Wuhan Zhong Yuan Rui De)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesWuhan Zhong Yuan Rui De Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Zhong Yuan Rui De Biological Products Co Ltd
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG